Publications

  • Spring 2012

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    Therapeutic Options: Focus on Alzheimer’s Disease

  • Annual Report 2010-11

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    A look at the activities of the Ontario Pharmacists Association over the past Board year (June 2010 – June 2011).

  • New Drugs/Drug News 2011, Volume 29, No. 3

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    Belimumab (Benlysta – Glaxosmithkline Inc.) for Systemic Lupus Erythematosus

  • New Drugs/Drug News 2011, Volume 29, No. 2

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    Roflumilast (Daxas – Nycomed Canada Inc.) for Severe Chronic Obstructive Pulmonary Disease

  • New Drugs/Drug News 2011, Volume 29, No. 1

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    Update on Sulfonamide Allergy and Cross-Reactivity

  • Full Financial Statements 2011

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    Full audited financial statements for the year ending December 31, 2011.

  • New Drugs/Drug News 2010, Volume 28, No. 5

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    Update on ASA/NSAID Sensitivity Reactions

  • Annual Report 2009-10

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    A look at the activities of the Ontario Pharmacists Association over the past Board year (June 2009 – June 2010).

  • New Drugs/Drug News 2010, Volume 28, No. 4

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    First-in-Class Drug Approval: Liraglutide (Victoza – Novo Nordisk Canada Inc.) for Type 2 Diabetes

  • New Drugs/Drug News 2010, Volume 28, No. 3

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    New Antiplatelet Agent: Prasugrel (Effient – Eli Lilly Canada Inc.)

Back to top